no_limit_pictures/iStock via Getty Images Investment Thesis Overview Inspire Medical Systems ( INSP ) is a mid-sized medical tech company that has established itself as the dominant commercial platform focused on the upper airway stimulation (UAS) therapy space. In particular, the company has positioned itself to target the obstructive sleep apnea (OAS) market, which is both large and structurally...
no_limit_pictures/iStock via Getty Images Investment Thesis Overview Inspire Medical Systems ( INSP ) is a mid-sized medical tech company that has established itself as the dominant commercial platform focused on the upper airway stimulation (UAS) therapy space. In particular, the company has positioned itself to target the obstructive sleep apnea (OAS) market, which is both large and structurally underpenetrated, due to the lack of any equivalent cure-rate alternative. Although boasting a solid competitive moat, the company's stock has experienced quite the fall in recent years, falling roughly 87% from its June 2023 all-time high of $326 to its current price of ~$42. This has brought the company's market capitalization down to $1.17 billion. Seeking Alpha As I will elaborate in this analysis, Inspire Medical's case does not seem to be one of a deteriorating business, but rather, the fall seems to be the result of identifiable and temporary technical lapses, which are currently suppressing procedure volumes. These lapses do not seem to pose a fundamental, existential, or even a clinical threat to the company. There are four pillars to my investment thesis: The headwinds facing the company are temporary and, in fact, potentially resolvable. The company's stellar balance sheet delivers to it strong downside insulation. We have a clear strategic floor above distress levels, established through the implied M&A takeout value. The company's governance structure is increasingly shifting towards one that is far more conducive to valuation realization. The Business The core product that sits at the center of Inspire's business is its FDA-approved implantable neurostimulation device. This ensures that the patient's hypoglossal nerve stimulation is actually synchronized to the breathing cycle. This synchronization is what prevents airway collapse, which is normally the main outcome in OSA. As an added strength, the device is covered by Medicare and other major commercial insu...
Key PointsSpaceX will be the largest IPO in history; the stock will have an initial market value of $1.77 trillion when it starts trading on Friday, June 12.
Key PointsSpaceX will be the largest IPO in history; the stock will have an initial market value of $1.77 trillion when it starts trading on Friday, June 12.
Forget about the May inflation report! The most anticipated event of the week, if not the year, is slated for Friday, June 12. This will mark the debut of Elon Musk's artificial intelligence (AI) and space economy conglomerate, SpaceX, which is raising $75 billion with its initial public offering (IPO) . The Dow Jones Industrial Average (DJINDICES: ^DJI) , S&P 500 (SNPINDEX: ^GSPC) , Nasdaq Compos...
Forget about the May inflation report! The most anticipated event of the week, if not the year, is slated for Friday, June 12. This will mark the debut of Elon Musk's artificial intelligence (AI) and space economy conglomerate, SpaceX, which is raising $75 billion with its initial public offering (IPO) . The Dow Jones Industrial Average (DJINDICES: ^DJI) , S&P 500 (SNPINDEX: ^GSPC) , Nasdaq Composite (NASDAQINDEX: ^IXIC) , and Nasdaq-100 have been abuzz ahead of this historic event. Aside from raising the bar for the largest-ever cash raise, we've witnessed a flurry of rule changes by brokerages and the committees that oversee index inclusion ahead of SpaceX's public debut. Image source: Getty Images. Continue reading
Another liquefied natural gas shipment from Qatar transited the Strait of Hormuz over the weekend, according to ship data, even as tension in the region threatens a broader peace deal between the US and Iran. The Al Daayen tanker, which loaded at Qatar’s Ras Laffan export plant in late-February, was spotted east of Oman on Monday heading to China, according to ship-tracking data compiled by Bloomb...
Another liquefied natural gas shipment from Qatar transited the Strait of Hormuz over the weekend, according to ship data, even as tension in the region threatens a broader peace deal between the US and Iran. The Al Daayen tanker, which loaded at Qatar’s Ras Laffan export plant in late-February, was spotted east of Oman on Monday heading to China, according to ship-tracking data compiled by Bloomberg. The tanker stopped broadcasting a signal around June 5, when it was idling near Ras Laffan in the Persian Gulf. The Strait of Hormuz has remained virtually shut as the US and Iran struggle to agree on a peace deal, with both sides enforcing a de facto blockade on a waterway that normally handles about a fifth of global LNG supply. Vessels face security threats, forcing LNG exporters to ask them to turn off transponders to avoid detection. So far, only eight other LNG shipments have been identified making it through Hormuz since the US and Israel started strikes against Iran at the end of February. That compares to roughly three tankers exiting the waterway on a daily basis before the war began. The latest transit comes as Israel and Iran exchanged missile strikes on Monday, despite US President Donald Trump calling for both sides to stop fighting and give peace talks a chance. Read More: The Iran War Is Pushing the Global Gas Trade Into the Shadows Seapeak, which manages Al Daayen, and QatarEnergy didn’t respond to requests for comment. The tanker has primarily exported fuel from Qatar over the last decade, according to data compiled by Bloomberg.